Literature DB >> 30773656

Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region.

Shailja C Shah1,2, Hamed Khalili3, Chung-Yu Chen4, Hyeong Sik Ahn5, Siew C Ng6, Johan Burisch2,7, Jean-Frederic Colombel2.   

Abstract

BACKGROUND: There appear to be differences in risk factor profiles for IBD between Asia-Pacific and Western populations, which might suggest idiosyncrasies in pathogenesis. Recently, sex-based differences in IBD according to the age of diagnosis have been described in Western populations. AIM: To identify whether sex-based differences in IBD incidence similarly exist across the age spectrum for Asia-Pacific populations.
METHODS: We identified Asia-Pacific population-based cohorts where IBD incidence data stratified by sex were available for the full age spectrum. Cohorts were included only if IBD diagnoses were confirmed and validated. We calculated incidence rate ratios of Crohn's disease (CD) and ulcerative colitis (UC) according to age and compared differences between males and females using random-effects meta-analysis.
RESULTS: Among 567.8 million people from 11 Asia-Pacific countries/provinces/nations, we identified 10 553 incident CD cases (7060 males; 3493 females) and 16 946 incident UC cases (9754 males; 7192 females). Starting in early adolescence until age 50 years, there was a 36%-64% higher incidence of CD in males vs females (P < 0.001). UC incidence ranged from 20%-42% higher in males vs females in the age groups between 15 and 65 years (P < 0.05).
CONCLUSIONS: In a pooled analysis of population-based studies from the Asia-Pacific region, we found a male predominance of both CD and UC for the majority of the age spectrum from adolescence to middle/late-middle age. Additional studies are needed to clarify biological and nonbiological determinants of sex differences in IBD, which might be distinct between Asia-Pacific and Western populations.
© 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 30773656     DOI: 10.1111/apt.15178

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

Review 1.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

2.  Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).

Authors:  Katsuyoshi Matsuoka; Toshimitsu Fujii; Ryuichi Okamoto; Akihiro Yamada; Reiko Kunisaki; Minoru Matsuura; Kenji Watanabe; Hisashi Shiga; Noritaka Takatsu; Shigeki Bamba; Yohei Mikami; Takayuki Yamamoto; Takahiro Shimoyama; Satoshi Motoya; Takehiro Torisu; Taku Kobayashi; Naoki Ohmiya; Masayuki Saruta; Koichiro Matsuda; Takayuki Matsumoto; Hiroshi Nakase; Atsuo Maemoto; Shinichiro Shinzaki; Yoko Murata; Shinichi Yoshigoe; Ayako Sasaki; Tsutomu Yajima; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2022-08-05       Impact factor: 6.772

Review 3.  Sex-based differences in inflammatory bowel diseases: a review.

Authors:  Sheila D Rustgi; Maia Kayal; Shailja C Shah
Journal:  Therap Adv Gastroenterol       Date:  2020-04-28       Impact factor: 4.409

4.  Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts.

Authors:  Ben Kang; Jung Eun Kim; Jae Hun Jung; Jae Young Choe; Mi Jin Kim; Yon Ho Choe; Seung Kim; Hong Koh; Yoo Min Lee; Jee Hyun Lee; Yoon Lee; Ji-Hyuk Lee; Hae Jeong Lee; Hyo-Jeong Jang; Youjin Choi; So Yoon Choi; Ju Young Kim; Byung-Ho Choe
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-01-09

5.  Clinical features and treatment of inflammatory bowel disease in a low-incidence area: A hospital-based retrospective cohort study in Taiwan.

Authors:  Hsu-Heng Yen; Tsui-Chun Hsu; Mei-Wen Chen; Pei-Yuan Su; Yang-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

6.  Thrombospondin-1 aggravates colonic mucosal inflammatory injuries via promoting the differentiation of CD11c+ macrophages with lysosomal activity limited in colitis.

Authors:  Ping Tao; Beiping Zhang; Jiang Lin; Shiying Wang
Journal:  Ann Transl Med       Date:  2021-12

7.  Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016.

Authors:  Hong Yang; Runing Zhou; Xiaoyin Bai; Mingyue Guo; Gechong Ruan; Li Wang; Jiaming Qian
Journal:  Front Med (Lausanne)       Date:  2022-07-25

8.  Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn's disease.

Authors:  Jiyoung Yoon; Dae Sung Kim; Ye-Jee Kim; Jin Wook Lee; Seung Wook Hong; Ha Won Hwang; Sung Wook Hwang; Sang Hyoung Park; Dong-Hoon Yang; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

9.  LncRNA NEAT1 mediates intestinal inflammation by regulating TNFRSF1B.

Authors:  Shiyu Pan; Rui Liu; Xing Wu; Kejia Ma; Weiwei Luo; Kai Nie; Chao Zhang; Xiangrui Meng; Ting Tong; Xuejie Chen; Xiaoyan Wang; Minzi Deng
Journal:  Ann Transl Med       Date:  2021-05

10.  Sex-related Alterations of Gut Microbiota in the C57BL/6 Mouse Model of Inflammatory Bowel Disease.

Authors:  Hee Jin Son; Nayoung Kim; Chin-Hee Song; Ryoung Hee Nam; Soo In Choi; Joo Sung Kim; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.